TY - JOUR AU - Grissette, Hanane AU - Nfaoui, EL Habib AU - Bahir, Adil PY - 2017/09/01 Y2 - 2024/03/28 TI - Sentiment Analysis Tool for Pharmaceutical Industry & Healthcare JF - Transactions on Engineering and Computing Sciences JA - TECS VL - 5 IS - 4 SE - Special Issue : 1st International Conference on Affective computing, Machine Learning and Intelligent Systems DO - 10.14738/tmlai.54.3339 UR - https://journals.scholarpublishing.org/index.php/TMLAI/article/view/3339 SP - AB - <p>Sentiment analysis (SA) is broadly used to analyze people’s opinions about a product or an event to identify breakpoints in public opinion. Particularly, pharmaceutical companies use SA to ensure they gain a competitive edge through better understanding of patients’ experiences allowing for more personalization and high responsiveness to consumers on social media. Patients self-reports on social media, frequently capture varied elements ranging from medical issues, product accessibility issues to potential side effects. The exploitation of such overwhelming unstructured data on social media through SA is of critical importance, however, the general-purpose sentiment analysis tools are not adapted and do not incorporate the specific lexicon used in the life sciences/pharma context which reduces the ability of such tools to accurately detect the meanings of the sentiments expressed towards treatments/scientific studies and pharma companies at large. Indeed, those tools involve generalized dictionaries, techniques and methods that face several challenges to detecting the suitable sentiment polarity. In this paper, we develop a dedicated research tool that extract in real time the sentiments and emotions conveyed by users on social media regarding pharmaceutical industries. Our focus is to improve the analyze of opinion about a target in pharmaceutical industries based on hybrid approaches used in single unified system throughout sentiment analysis process to seek the relevant sentiment polarity, which is tailored specifically to detect positive, negative or neutral opinions of patients and consumer health. This paper proposes a first architecture validated by a real and industry case.</p><p> </p><p class="Abstract"><em><br /></em></p> ER -